Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, signaling an access restriction rather than an update to the study details.SummaryDifference17%

- Check38 days agoChange DetectedRevision indicates the platform was updated from v3.6.5 to v3.6.6, a minor version bump. This update does not alter study data, eligibility criteria, or other core content on the page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5, indicating a new build/deployment. No visible content or functionality changes were made.SummaryDifference0.1%

- Check73 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a minor version bump with no visible changes to the study details.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor backend/content-management update.SummaryDifference0.1%

- Check102 days agoChange DetectedThe page now displays a new revision tag (v3.6.2) replacing the previous v3.6.0, signaling a more recent deployment of the page.SummaryDifference0.1%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.